Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Exogenous KGF is not Required for Pigmentation of Skin Substitutes with Three Isogeneic Cell Types.

Boyce ST, Supp DM, Lloyd CM.

Tissue Eng Part A. 2019 Sep 27. doi: 10.1089/ten.TEA.2019.0203. [Epub ahead of print]

PMID:
31559928
2.

Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes.

Supp DM, Hahn JM, Combs KA, McFarland KL, Schwentker A, Boissy RE, Boyce ST, Powell HM, Lucky AW.

Cell Transplant. 2019 Sep-Oct;28(9-10):1242-1256. doi: 10.1177/0963689719857657. Epub 2019 Jul 4.

PMID:
31271052
3.

Identification of Merkel cells associated with neurons in engineered skin substitutes after grafting to full thickness wounds.

Hahn JM, Combs KA, Lloyd CM, McFarland KL, Boyce ST, Supp DM.

PLoS One. 2019 Mar 5;14(3):e0213325. doi: 10.1371/journal.pone.0213325. eCollection 2019.

4.

Role of Early Application of Pressure Garments following Burn Injury and Autografting.

DeBruler DM, Baumann ME, Blackstone BN, Zbinden JC, McFarland KL, Bailey JK, Supp DM, Powell HM.

Plast Reconstr Surg. 2019 Feb;143(2):310e-321e. doi: 10.1097/PRS.0000000000005270.

PMID:
30688890
5.

Inflammatory response and biomechanical properties of coaxial scaffolds for engineered skin in vitro and post-grafting.

Blackstone BN, Hahn JM, McFarland KL, DeBruler DM, Supp DM, Powell HM.

Acta Biomater. 2018 Oct 15;80:247-257. doi: 10.1016/j.actbio.2018.09.014. Epub 2018 Sep 12.

PMID:
30218778
6.

Structural, Chemical, and Mechanical Properties of Pressure Garments as a Function of Simulated Use and Repeated Laundering.

Malara MM, Kim JY, Clark JA, Blackstone BN, Ruegsegger MA, Bailey JK, Supp DM, Powell HM.

J Burn Care Res. 2018 Jun 13;39(4):562-571. doi: 10.1093/jbcr/irx018.

PMID:
29901806
7.

Early cessation of pressure garment therapy results in scar contraction and thickening.

DeBruler DM, Zbinden JC, Baumann ME, Blackstone BN, Malara MM, Bailey JK, Supp DM, Powell HM.

PLoS One. 2018 Jun 13;13(6):e0197558. doi: 10.1371/journal.pone.0197558. eCollection 2018.

8.

Effect of skin graft thickness on scar development in a porcine burn model.

DeBruler DM, Blackstone BN, McFarland KL, Baumann ME, Supp DM, Bailey JK, Powell HM.

Burns. 2018 Jun;44(4):917-930. doi: 10.1016/j.burns.2017.11.011. Epub 2018 Apr 13.

PMID:
29661554
9.

Analysis of chromatin accessibility in human epidermis identifies putative barrier dysfunction-sensing enhancers.

Lander JM, Supp DM, He H, Martin LJ, Chen X, Weirauch MT, Boyce ST, Kopan R.

PLoS One. 2017 Sep 27;12(9):e0184500. doi: 10.1371/journal.pone.0184500. eCollection 2017.

10.

Abnormal expression of the vitamin D receptor in keloid scars.

Hahn JM, Supp DM.

Burns. 2017 Nov;43(7):1506-1515. doi: 10.1016/j.burns.2017.04.009. Epub 2017 Aug 1.

PMID:
28778755
11.

Effects of early combinatorial treatment of autologous split-thickness skin grafts in red duroc pig model using pulsed dye laser and fractional CO2 laser.

Bailey JK, Blackstone BN, DeBruler DM, Kim JY, Baumann ME, McFarland KL, Imeokparia FO, Supp DM, Powell HM.

Lasers Surg Med. 2018 Jan;50(1):78-87. doi: 10.1002/lsm.22702. Epub 2017 Jul 31.

PMID:
28759110
12.

Scar formation following excisional and burn injuries in a red Duroc pig model.

Blackstone BN, Kim JY, McFarland KL, Sen CK, Supp DM, Bailey JK, Powell HM.

Wound Repair Regen. 2017 Aug;25(4):618-631. doi: 10.1111/wrr.12562. Epub 2017 Jul 31.

13.

Restoration of cutaneous pigmentation by transplantation to mice of isogeneic human melanocytes in dermal-epidermal engineered skin substitutes.

Boyce ST, Lloyd CM, Kleiner MC, Swope VB, Abdel-Malek Z, Supp DM.

Pigment Cell Melanoma Res. 2017 Jan;30(6):531-540. doi: 10.1111/pcmr.12609. Epub 2017 Oct 19.

PMID:
28640957
14.

Inflammatory responses, matrix remodeling, and re-epithelialization after fractional CO2 laser treatment of scars.

DeBruler DM, Blackstone BN, Baumann ME, McFarland KL, Wulff BC, Wilgus TA, Bailey JK, Supp DM, Powell HM.

Lasers Surg Med. 2017 Sep;49(7):675-685. doi: 10.1002/lsm.22666. Epub 2017 May 10.

PMID:
28489283
15.

Soluble Epoxide Hydrolase Inhibition and Epoxyeicosatrienoic Acid Treatment Improve Vascularization of Engineered Skin Substitutes.

Supp DM, Hahn JM, McFarland KL, Combs KA, Lee KS, Inceoglu B, Wan D, Boyce ST, Hammock BD.

Plast Reconstr Surg Glob Open. 2016 Dec 20;4(12):e1151. doi: 10.1097/GOX.0000000000001151. eCollection 2016 Dec.

16.

Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1.

Hahn JM, McFarland KL, Combs KA, Supp DM.

Burns Trauma. 2016 Aug 23;4(1):30. doi: 10.1186/s41038-016-0055-7. eCollection 2016.

17.

Novel burn device for rapid, reproducible burn wound generation.

Kim JY, Dunham DM, Supp DM, Sen CK, Powell HM.

Burns. 2016 Mar;42(2):384-91. doi: 10.1016/j.burns.2015.08.027. Epub 2016 Jan 21.

18.

Burn Scar Biomechanics after Pressure Garment Therapy.

Kim JY, Willard JJ, Supp DM, Roy S, Gordillo GM, Sen CK, Powell HM.

Plast Reconstr Surg. 2015 Sep;136(3):572-81. doi: 10.1097/PRS.0000000000001507.

19.

Role of Arginine and Omega-3 Fatty Acids in Wound Healing and Infection.

Alexander JW, Supp DM.

Adv Wound Care (New Rochelle). 2014 Nov 1;3(11):682-690. Review.

20.

Tumorigenicity Testing in Athymic Mice of Cultured Human Melanocytes for Transplantation in Engineered Skin Substitutes.

Boyce ST, Zimmerman RL, Supp DM.

Cell Transplant. 2015;24(8):1423-9. doi: 10.3727/096368914X683052. Epub 2014 Jul 23.

PMID:
25199067
21.

Inhibition of hyaluronan synthase 2 reduces the abnormal migration rate of keloid keratinocytes.

Supp DM, Hahn JM, McFarland KL, Glaser K.

J Burn Care Res. 2014 Jan-Feb;35(1):84-92. doi: 10.1097/BCR.0b013e3182a2a9dd.

PMID:
24043232
22.

Concerns over interspecies transcriptional comparisons in mice and humans after trauma.

Osterburg AR, Hexley P, Supp DM, Robinson CT, Noel G, Ogle C, Boyce ST, Aronow BJ, Babcock GF.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3370. doi: 10.1073/pnas.1306033110. Epub 2013 Jul 11. No abstract available.

23.

Keloid-derived keratinocytes exhibit an abnormal gene expression profile consistent with a distinct causal role in keloid pathology.

Hahn JM, Glaser K, McFarland KL, Aronow BJ, Boyce ST, Supp DM.

Wound Repair Regen. 2013 Jul-Aug;21(4):530-44. doi: 10.1111/wrr.12060.

PMID:
23815228
24.

Characterization of hair follicle development in engineered skin substitutes.

Sriwiriyanont P, Lynch KA, McFarland KL, Supp DM, Boyce ST.

PLoS One. 2013 Jun 17;8(6):e65664. doi: 10.1371/journal.pone.0065664. Print 2013.

25.

Morphogenesis of chimeric hair follicles in engineered skin substitutes with human keratinocytes and murine dermal papilla cells.

Sriwiriyanont P, Lynch KA, Maier EA, Hahn JM, Supp DM, Boyce ST.

Exp Dermatol. 2012 Oct;21(10):783-5. doi: 10.1111/exd.12003.

PMID:
23078401
26.

Assessment of replication rates of human keratinocytes in engineered skin substitutes grafted to athymic mice.

Boyce ST, Rice RK, Lynch KA, Supp AP, Swope VB, Kagan RJ, Supp DM.

Wound Repair Regen. 2012 Jul-Aug;20(4):544-51. doi: 10.1111/j.1524-475X.2012.00807.x. Epub 2012 Jun 7.

PMID:
22672265
27.

Deep and superficial keloid fibroblasts contribute differentially to tissue phenotype in a novel in vivo model of keloid scar.

Supp DM, Hahn JM, Glaser K, McFarland KL, Boyce ST.

Plast Reconstr Surg. 2012 Jun;129(6):1259-71. doi: 10.1097/PRS.0b013e31824ecaa9.

PMID:
22634643
28.

Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3.

Swope VB, Jameson JA, McFarland KL, Supp DM, Miller WE, McGraw DW, Patel MA, Nix MA, Millhauser GL, Babcock GF, Abdel-Malek ZA.

J Invest Dermatol. 2012 Sep;132(9):2255-62. doi: 10.1038/jid.2012.135. Epub 2012 May 10.

29.

LETTER TO THE EDITOR Abnormal Responses of Keloid Tissue to Wounding Identified Using In Vitro Model System.

Supp DM, Glaser K, Hahn JM, McFarland KL, Boyce ST.

Eplasty. 2012;12:e19. Epub 2012 Apr 12. No abstract available.

30.
31.

Culture medium and cell density impact gene expression in normal skin and abnormal scar-derived fibroblasts.

McFarland KL, Glaser K, Hahn JM, Boyce ST, Supp DM.

J Burn Care Res. 2011 Jul-Aug;32(4):498-508. doi: 10.1097/BCR.0b013e3182223cb1.

PMID:
21747336
32.

Local expression of indoleamine 2,3-dioxygenase suppresses T-cell-mediated rejection of an engineered bilayer skin substitute.

Forouzandeh F, Jalili RB, Hartwell RV, Allan SE, Boyce S, Supp D, Ghahary A.

Wound Repair Regen. 2010 Nov-Dec;18(6):614-23. doi: 10.1111/j.1524-475X.2010.00635.x. Epub 2010 Oct 18.

PMID:
20955343
33.

Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation.

Kadekaro AL, Leachman S, Kavanagh RJ, Swope V, Cassidy P, Supp D, Sartor M, Schwemberger S, Babcock G, Wakamatsu K, Ito S, Koshoffer A, Boissy RE, Manga P, Sturm RA, Abdel-Malek ZA.

FASEB J. 2010 Oct;24(10):3850-60. doi: 10.1096/fj.10-158485. Epub 2010 Jun 2.

34.

Uniaxial strain regulates morphogenesis, gene expression, and tissue strength in engineered skin.

Powell HM, McFarland KL, Butler DL, Supp DM, Boyce ST.

Tissue Eng Part A. 2010 Mar;16(3):1083-92. doi: 10.1089/ten.TEA.2009.0542.

PMID:
19845460
35.

Engineered human skin substitutes undergo large-scale genomic reprogramming and normal skin-like maturation after transplantation to athymic mice.

Klingenberg JM, McFarland KL, Friedman AJ, Boyce ST, Aronow BJ, Supp DM.

J Invest Dermatol. 2010 Feb;130(2):587-601. doi: 10.1038/jid.2009.295. Epub 2009 Oct 1.

36.

Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.

Supp DM, Gardner J, Klingenberg JM, Neely AN.

Burns. 2009 Nov;35(7):949-55. doi: 10.1016/j.burns.2009.02.016. Epub 2009 Jun 6.

PMID:
19501982
37.

Expression of genes encoding antimicrobial proteins and members of the toll-like receptor/nuclear factor-kappaB pathways in engineered human skin.

McFarland KL, Klingenberg JM, Boyce ST, Supp DM.

Wound Repair Regen. 2008 Jul-Aug;16(4):534-41. doi: 10.1111/j.1524-475X.2008.00401.x.

PMID:
18638273
38.

Medium flow rate regulates viability and barrier function of engineered skin substitutes in perfusion culture.

Kalyanaraman B, Supp DM, Boyce ST.

Tissue Eng Part A. 2008 May;14(5):583-93. doi: 10.1089/tea.2007.0237.

PMID:
18399733
39.

beta-Defensin 3: a novel and unexpected key that unlocks the melanocortin 1 receptor.

Abdel-Malek ZA, Supp D.

Pigment Cell Melanoma Res. 2008 Feb;21(1):7-8. doi: 10.1111/j.1755-148X.2007.00435.x. No abstract available.

PMID:
18353137
40.

Influence of electrospun collagen on wound contraction of engineered skin substitutes.

Powell HM, Supp DM, Boyce ST.

Biomaterials. 2008 Mar;29(7):834-43. Epub 2007 Dec 3.

PMID:
18054074
41.

GSK-3beta activity is increased in skeletal muscle after burn injury in rats.

Fang CH, Li B, James JH, Yahya A, Kadeer N, Guo X, Xiao C, Supp DM, Kagan RJ, Hasselgren PO, Sheriff S.

Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1545-51. Epub 2007 Aug 8.

42.

Gene therapy to fight infection in skin transplants.

Supp DM.

Pharmacogenomics. 2007 May;8(5):483-6. No abstract available.

PMID:
17465712
43.

Expression of human beta defensin 4 in genetically modified keratinocytes enhances antimicrobial activity.

Smiley AK, Gardner J, Klingenberg JM, Neely AN, Supp DM.

J Burn Care Res. 2007 Jan-Feb;28(1):127-32.

PMID:
17211212
44.

Remanent zero field spin splitting of self-assembled quantum dots in a paramagnetic host.

Gould C, Slobodskyy A, Supp D, Slobodskyy T, Grabs P, Hawrylak P, Qu F, Schmidt G, Molenkamp LW.

Phys Rev Lett. 2006 Jul 7;97(1):017202. Epub 2006 Jul 6.

PMID:
16907404
45.
46.

Microarray analysis of gene expression in cultured skin substitutes compared with native human skin.

Smiley AK, Klingenberg JM, Aronow BJ, Boyce ST, Kitzmiller WJ, Supp DM.

J Invest Dermatol. 2005 Dec;125(6):1286-301.

47.

Engineered skin substitutes: practices and potentials.

Supp DM, Boyce ST.

Clin Dermatol. 2005 Jul-Aug;23(4):403-12. Review.

PMID:
16023936
48.
49.

Supplemental Content

Support Center